Advisors Asset Management Inc. Acquires 9,037 Shares of The Clorox Company (NYSE:CLX)

Advisors Asset Management Inc. boosted its holdings in The Clorox Company (NYSE:CLX) by 43.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,865 shares of the company’s stock after buying an additional 9,037 shares during the quarter. Advisors Asset Management Inc.’s holdings in Clorox were worth $4,865,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in CLX. Lake Street Advisors Group LLC bought a new position in Clorox in the 1st quarter valued at approximately $250,000. Natixis raised its holdings in Clorox by 707.8% in the 1st quarter. Natixis now owns 13,175 shares of the company’s stock valued at $2,017,000 after buying an additional 11,544 shares during the last quarter. EntryPoint Capital LLC bought a new position in Clorox during the 1st quarter worth approximately $39,000. CreativeOne Wealth LLC bought a new position in Clorox during the 1st quarter worth approximately $229,000. Finally, Canada Pension Plan Investment Board raised its holdings in Clorox by 39.4% during the 1st quarter. Canada Pension Plan Investment Board now owns 347,894 shares of the company’s stock worth $53,266,000 after purchasing an additional 98,391 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 11.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.57% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on CLX shares. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and raised their price target for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Barclays raised their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Citigroup raised their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their price target for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $155.00.

Clorox Stock Performance

NYSE CLX opened at $169.06 on Friday. The company has a fifty day simple moving average of $162.72 and a 200 day simple moving average of $148.22. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $169.21. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The company has a market cap of $20.93 billion, a P/E ratio of 58.91, a PEG ratio of 3.11 and a beta of 0.41.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 EPS. Sell-side analysts predict that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.89%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.